Europe Anti-Infective Agents Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Range, Route of Administration, Indication, and Distribution Channel

Description

List of Tables

The Europe anti-infectives agents market is likely to be US$ 41,446.62 million in 2022 and is projected to reach US$ 49,527.90 million by 2028. It is expected to grow at a CAGR of 3.0% during the forecast period.

Increasing government support for research activities and clinical trials is driving the Europe anti-infective agents market substantially. The clinical trials industry has seen exceptional growth in the last 10 years. The FDA awarded grants through the Orphan Products Clinical Trials Grants Program, which Congress funds to promote the clinical development of medical foods, biologics, drugs, and medical devices to treat rare diseases. Grants are intended to considerably contribute to the marketing approval of products to treat rare diseases and provide essential data for developing such products. For clinical trials of possibly life-changing treatments for patients with rare diseases, the FDA has been offering much-needed financial support for more than 35 years. In addition, the Orphan Products Clinical Trials Grants Program's contributions have supported research that will lead to the marketing approval of treatments for rare diseases in the near future.

COVID-19 Vaccines are developing significantly because more participants are focusing on clinical trials and collaborating to make certain rapid growth and sufficient production capacity. In addition, the UK government has committed to providing US$ 99.9 million (£84 million) in funding and manufacturing support to researchers to work on the COVID-19 vaccine program. Hence, government funding for research activities and clinical trials is aiding the development of new therapies, thereby boosting the anti-infective agent market.

Vendors can attract new customers and expand their footprints in emerging markets with new features and technologies. This factor is likely to drive the Europe anti-infective agents market at a good CAGR during the forecast period.

Europe Anti-Infective Agents Market Revenue and Forecast to 2028 (US$ Million)

Europe Anti-Infective Agents Market Segmentation

The Europe anti-infective agents market is segmented based on type, range, route of administration, indication, distribution channel, and country. Based on type, the market is segmented into anti-bacterial, anti-viral, anti-fungal, and others. The anti-viral segment is expected to account for the largest market share by the end of 2022.

Based on range, the market is segmented into broad spectrum and narrow spectrum. By the end of 2022, the narrow spectrum segment will likely hold a larger market share.

Based on route of administration, the market is segmented into topical, oral, IV, and others. By the end of 2022, the IV segment is likely to hold the largest market share.

Based on indication, the market is segmented into HIV, tuberculosis, respiratory infection, pneumonia, and others. In 2022, the others segment is projected to hold the largest share of the market.

Based on distribution channel, the market is segmented into hospital pharmacies, specialty pharmacies, e-commerce, and others. By the end of 2022, the hospital pharmacies segment is likely to hold the largest market share.

Based on country, the market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany is expected to hold the largest market share by the end of 2022.

Abbott; Allergan Plc.; Astellas Pharma Inc.; Bayer AG; Boehringer Ingelheim International GmbH; Bristol-Myers Squibb Company; F. Hoffmann-La Roche Ltd.; Gilead Sciences, Inc.; GlaxoSmithKline plc.; Merck & Co., Inc.; and Novartis AG are the leading companies in the Europe anti-infective agents market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe anti-infective agents market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe anti-infective agents market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the anti-infective agents market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Product Code: BMIRE00025824

1. Introduction

1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Europe Anti-Infective Agents Market - By Type
- 1.3.2 Europe Anti-Infective Agents Market - By Range
- 1.3.3 Europe Anti-Infective Agents Market - By Route of Administration
- 1.3.4 Europe Anti-Infective Agents Market - By Indication
- 1.3.5 Europe Anti-Infective Agents Market - By Distribution Channel
- 1.3.6 Europe Anti-Infective Agents Market - By Country

2. Europe Anti-Infective Agents Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Anti-infective agents Market - Market Landscape

4.1 Overview
4.2 Europe PEST Analysis
4.3 Experts Opinion

5. Europe Anti-Infectives Agents Market - Key Market Dynamics

5.1 Key Drivers
- 5.1.1 Chronic Diseases Rising
- 5.1.2 Increasing Government Support for Research Activities and Clinical Trials
5.2 Market Restraints
- 5.2.1 Emergence of Anti-infective Drugs Resistance and Their Side Effects
5.3 Market Opportunities
- 5.3.1 Upcoming of New Anti-infective Agents
5.4 Future Trends
- 5.4.1 Rising Investments in R&D Activities in Pharmaceutical Sector
5.5 Impact Analysis

6. Anti-Infectives Agents Market - Europe Analysis

6.1 Europe Anti-Infectives Agents Market Revenue Forecast and Analysis

7. Europe Anti-Infectives Agents Market Analysis and Forecast to 2028 - Type

7.1 Overview
7.2 Europe Anti-infectives Agents Market, by Type, 2022 & 2028 (%)
7.3 Anti-Viral
- 7.3.1 Overview
- 7.3.2 Anti-Viral Market Revenue and Forecast to 2028 (US$ Million)
7.4 Anti-Bacterial
- 7.4.1 Overview
- 7.4.2 Anti-Bacterial Market Revenue and Forecast to 2028 (US$ Million)
7.5 Anti-Fungal
- 7.5.1 Overview
- 7.5.2 Anti-Fungal Market Revenue and Forecast to 2028 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)

8. Europe Anti-Infectives Agents Market Analysis and Forecast to 2028 - Range

8.1 Overview
8.2 Europe Anti-Infectives Agents Market, by Range, 2022 & 2028 (%)
8.3 Narrow Spectrum
- 8.3.1 Overview
- 8.3.2 Narrow Spectrum Market Revenue and Forecast to 2028 (US$ Million)
8.4 Broad Spectrum
- 8.4.1 Overview
- 8.4.2 Broad Spectrum Market Revenue and Forecast to 2028 (US$ Million)

9. Europe Anti-Infectives Agents Market Analysis and Forecast to 2028 - Route of Administration

9.1 Overview
9.2 Europe Anti-Infectives Agents Market, by Route of Administration, 2022 & 2028 (%)
9.3 IV
- 9.3.1 Overview
- 9.3.2 IV Market Revenue and Forecast to 2028 (US$ Million)
9.4 Oral
- 9.4.1 Overview
- 9.4.2 Oral Market Revenue and Forecast to 2028 (US$ Million)
9.5 Topical
- 9.5.1 Overview
- 9.5.2 Topical Market Revenue and Forecast to 2028 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)

10. Europe Anti-Infectives Agents Market Analysis and Forecast to 2028 - Indication

10.1 Overview
10.2 Europe Anti-Infectives Agents Market, by Indication, 2022 & 2028 (%)
10.3 HIV
- 10.3.1 Overview
- 10.3.2 HIV Market Revenue and Forecast to 2028 (US$ Million)
10.4 Tuberculosis
- 10.4.1 Overview
- 10.4.2 Tuberculosis Market Revenue and Forecast to 2028 (US$ Million)
10.5 Respiratory Infection
- 10.5.1 Overview
- 10.5.2 Respiratory Infection Market Revenue and Forecast to 2028 (US$ Million)
10.6 Pneumonia
- 10.6.1 Overview
- 10.6.2 Pneumonia Market Revenue and Forecast to 2028 (US$ Million)
10.7 Others
- 10.7.1 Overview
- 10.7.2 Others Market Revenue and Forecast to 2028 (US$ Million)

11. Europe Anti-Infectives Agents Market Analysis and Forecast to 2028 - Distribution Channel

11.1 Overview
11.2 Europe Anti-Infectives Agents Market, by Distribution Channel, 2022 & 2028 (%)
11.3 Hospital Pharmacies
- 11.3.1 Overview
- 11.3.2 Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
11.4 Retail Pharmacies
- 11.4.1 Overview
- 11.4.2 Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
11.5 Specialty Pharmacies
- 11.5.1 Overview
- 11.5.2 Specialty Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
11.6 E-Commerce
- 11.6.1 Overview
- 11.6.2 E-Commerce Market Revenue and Forecast to 2028 (US$ Million)
11.7 Others
- 11.7.1 Overview
- 11.7.2 Others Market Revenue and Forecast to 2028 (US$ Million)

12. Europe Anti-Infectives Agents Market Analysis and Forecasts To 2028 - Country Analysis

12.1 Overview
- 12.1.1 Europe: Anti-Infectives Agents Market, by Country, 2022 & 2028 (%)
  - 12.1.1.1 Germany: Anti-Infectives Agents Market - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.1.1.1 Overview
    - 12.1.1.1.2 Germany: Anti-Infectives Agents Market - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.1.1.3 Germany: Anti-infectives Agents Market, by Type, 2019-2028 (US$ Million)
    - 12.1.1.1.4 Germany: Anti-infectives Agents Market, by Range, 2019-2028 (US$ Million)
    - 12.1.1.1.5 Germany: Anti-infectives Agents Market, by Route of Administration, 2019-2028 (US$ Million)
    - 12.1.1.1.6 Germany: Anti-infectives Agents Market, by Indication, 2019-2028 (US$ Million)
    - 12.1.1.1.7 Germany: Anti-infectives Agents Market, by Distribution Channel, 2019-2028 (US$ Million)
  - 12.1.1.2 UK: Anti-Infectives Agents Market - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.1.2.1 Overview
    - 12.1.1.2.2 UK: Anti-Infectives Agents Market - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.1.2.3 UK: Anti-infectives Agents Market, by Type, 2019-2028 (US$ Million)
    - 12.1.1.2.4 UK: Anti-infectives Agents Market, by Range, 2019-2028 (US$ Million)
    - 12.1.1.2.5 UK: Anti-infectives Agents Market, by Route of Administration, 2019-2028 (US$ Million)
    - 12.1.1.2.6 UK: Anti-infectives Agents Market, by Indication, 2019-2028 (US$ Million)
    - 12.1.1.2.7 UK: Anti-infectives Agents Market, by Distribution Channel, 2019-2028 (US$ Million)
  - 12.1.1.3 France: Anti-Infectives Agents Market - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.1.3.1 Overview
    - 12.1.1.3.2 France: Anti-Infectives Agents Market - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.1.3.3 France: Anti-infectives Agents Market, by Type, 2019-2028 (US$ Million)
    - 12.1.1.3.4 France: Anti-infectives Agents Market, by Range, 2019-2028 (US$ Million)
    - 12.1.1.3.5 France: Anti-infectives Agents Market, by Route of Administration, 2019-2028 (US$ Million)
    - 12.1.1.3.6 France: Anti-infectives Agents Market, by Indication, 2019-2028 (US$ Million)
    - 12.1.1.3.7 France: Anti-infectives Agents Market, by Distribution Channel, 2019-2028 (US$ Million)
  - 12.1.1.4 Italy: Anti-Infectives Agents Market - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.1.4.1 Overview
    - 12.1.1.4.2 Italy: Anti-Infectives Agents Market - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.1.4.3 Italy: Anti-Infectives Agents Market, by Type, 2019-2028 (US$ Million)
    - 12.1.1.4.4 Italy: Anti-Infectives Agents Market, by Range, 2019-2028 (US$ Million)
    - 12.1.1.4.5 Italy: Anti-Infectives Agents Market, by Route of Administration, 2019-2028 (US$ Million)
    - 12.1.1.4.6 Italy: Anti-Infectives Agents Market, by Indication, 2019-2028 (US$ Million)
    - 12.1.1.4.7 Italy: Anti-Infectives Agents Market, by Distribution Channel, 2019-2028 (US$ Million)
  - 12.1.1.5 Spain: Anti-Infectives Agents Market - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.1.5.1 Overview
    - 12.1.1.5.2 Spain: Anti-Infectives Agents Market - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.1.5.3 Spain: Anti-Infectives Agents Market, by Type, 2019-2028 (US$ Million)
    - 12.1.1.5.4 Spain: Anti-Infectives Agents Market, by Range, 2019-2028 (US$ Million)
    - 12.1.1.5.5 Spain: Anti-Infectives Agents Market, by Route of Administration, 2019-2028 (US$ Million)
    - 12.1.1.5.6 Spain: Anti-Infectives Agents Market, by Indication, 2019-2028 (US$ Million)
    - 12.1.1.5.7 Spain: Anti-Infectives Agents Market, by Distribution Channel, 2019-2028 (US$ Million)
  - 12.1.1.6 Rest of Europe: Anti-Infectives Agents Market - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.1.6.1 Overview
    - 12.1.1.6.2 Rest of Europe: Anti-Infectives Agents Market - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.1.6.3 Rest of Europe: Anti-infectives Agents Market, by Type, 2019-2028 (US$ Million)
    - 12.1.1.6.4 Rest of Europe: Anti-infectives Agents Market, by Range, 2019-2028 (US$ Million)
    - 12.1.1.6.5 Rest of Europe: Anti-infectives Agents Market, by Route of Administration, 2019-2028 (US$ Million)
    - 12.1.1.6.6 Rest of Europe: Anti-infectives Agents Market, by Indication, 2019-2028 (US$ Million)
    - 12.1.1.6.7 Rest of Europe: Anti-infectives Agents Market, by Distribution Channel, 2019-2028 (US$ Million)

13. Anti-infectives Agents Market-Industry Landscape

13.1 Overview
13.2 Growth Strategies In The Anti-infective agents Market, 2018-2022
13.3 Organic Developments
- 13.3.1 Overview
- 13.3.2 Organic Growth Strategies In The Anti-infective agents Market, 2018-2022
13.4 Inorganic Developments
- 13.4.1 Overview
- 13.4.2 Inorganic Growth Strategies In The Anti-infective agents Market, 2018-2022

14. Anti-Infectives Agents Market- Company Profiles

14.1 Abbott
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Allergan Plc.
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Astellas Pharma Inc.
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Merck & Co., Inc.
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Bayer AG
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Bristol-Myers Squibb Company
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Boehringer Ingelheim International GmbH
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 F. HOFFMANN-LA ROCHE LTD.
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Gilead Sciences, Inc.
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 GlaxoSmithKline plc.
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
14.11 Novartis AG
- 14.11.1 Key Facts
- 14.11.2 Business Description
- 14.11.3 Products and Services
- 14.11.4 Financial Overview
- 14.11.5 SWOT Analysis
- 14.11.6 Key Developments

15. Appendix

15.1 About The Insight Partners
15.2 Glossary of Terms